The pharma giant announced the decision to change its name to GSK in an April 27 earnings release, but officially made the change May 16.
The company said the name change will soon be reflected in the London Stock Exchange and the New York Stock Exchange.
The switch to the three-letter acronym comes as the British drugmaker is working on a planned de-merger to spin out its consumer healthcare business by mid-2022.
In February, GSK announced its consumer healthcare arm would be called Haleon and will include brands such as Advil, Panadol, Excedrin, Centrum multivitamin and Tums.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
